Histamine in cancer immunology and immunotherapy. Current status and new perspectives
Abstract Cancer is the second leading cause of death globally and its incidence and mortality are rapidly increasing worldwide. The dynamic interaction of immune cells and tumor cells determines the clinical outcome of cancer. Immunotherapy comes to the forefront of cancer treatments, resulting in i...
Enregistré dans:
Auteurs principaux: | María de la Paz Sarasola, Mónica A. Táquez Delgado, Melisa B. Nicoud, Vanina A. Medina |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Wiley
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/a35b5b0c681848ef9c7012a61da8b6be |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
CHEMOKINE SECRETION PATTERNS IN MONONUCLEAR AND DENDRITIC CELLS: ROLE OF HISTAMINE TYPE H3/H4 RECEPTORS
par: V. S. Evstratova, et autres
Publié: (2016) -
Immunotropic effects of mesotherapy used for correction of age-related skin changes
par: L. P. Sizyakina, et autres
Publié: (2021) -
FORMATION OF INNATE AND ADAPTIVE IMMUNE RESPONSE UNDER THE INFLUENCE OF DIFFERENT FLAVIVIRUS VACCINES
par: N. V. Krylova
Publié: (2015) -
Immunotherapy of cancer tumors with inhibition of PD-1 membrane protein and its ligands interaction
par: A. V. Chetveryakov, et autres
Publié: (2021) -
Nature immunology
Publié: (2000)